0.71 USD
▼-0.13-15.06%
盘后 0.72 +2.41%
2026-11-20
市值
$4.90M
市盈率
—
EPS
-2.77
股息率
—
52 周区间
0.62 – 9.60
成交量
49.53K
Beta
1.84
目标价
11.50
52W 低 0.6252W 高 9.60
价格走势
公司简介
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, includi...